Effect of 25-hydroxycholecalciferol (25-HCC) on intestinal absorption of 47Ca in four cases of iatrogenic Cushing's syndrome.
D000324:Adrenocorticotropic Hormone / Q000009:adverse effects; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D002118:Calcium / Q000097:blood / Q000378:metabolism* / Q000652:urine; D002132:Calcium Radioisotopes; D003480:Cushing Syndrome / Q000097:blood / Q000139:chemically induced / Q000378:metabolism* / Q000652:urine; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000378:metabolism* / Q000627:therapeutic use; D006909:Hydroxyproline / Q000097:blood / Q000652:urine; D007049:Iatrogenic Disease; D007408:Intestinal Absorption; D008286:Malabsorption Syndromes / Q000097:blood / Q000188:drug therapy / Q000652:urine; D008875:Middle Aged
D002132:Calcium Radioisotopes; D006887:Hydroxycholecalciferols; D000324:Adrenocorticotropic Hormone; D000469:Alkaline Phosphatase; D006909:Hydroxyproline; D002118:Calcium